Parasym is a health tech company founded in 2015 and headquartered in London, UK, specializing in non-invasive neuromodulation technology.
Its products include Nurosym® and Nuropod, which use Auricular Vagal Neuromodulation Therapy (AVNT™) to support accessible, drug-free care for nervous system regulation and overall well-being.
Nuropod has been studied in collaboration with institutions such as Harvard and UCLA and is designed to target the vagus nerve via the ear without a prescription.
Parasym's mission is to develop science-based neurotechnology that supports improved quality of life through a non-invasive approach.